Stanford prof. turns terminal cancer diagnosis into life-changing lesson for students, world
The 10-week course at Stanford last fall was fully enrolled and packed with students eager to learn from Dr. Lin's unique ...
MyStateline.com on MSN6h
Rockford doctor works with her students to find quicker ways to detect lung cancer
Dr. Neelu Puri is leading lung cancer research at the University of Illinois College of Medicine Rockford, promoting early ...
CURE14h
First Patient Dosed with Efti in Phase 3 Trial for Non-Small Cell Lung Cancer
The first patient has been dosed in the phase 3 TACTI-004 trial evaluating efti with Keytruda and chemotherapy for advanced ...
Increased use of chest X-rays linked to earlier lung cancer diagnosis and improved survival
A groundbreaking study has revealed a significant link between the frequency of chest X-ray referrals from GPs and earlier ...
QNS14h
NY Senate passes bill to expand free lung cancer screenings; Assembly vote pending
The New York State Senate has unanimously passed Senate Bill S. 2000, a significant step toward improving the early detection ...
First Patient Dosed in Immutep’s TACTI-004 Phase III Trial in First Line Non-Small Cell Lung Cancer
First patient safely dosed at Calvary Mater Newcastle Hospital in Australia, marking a significant milestone for ...
Study Finds on MSN7d
‘Western Diet’ May Create Cancer-Friendly Conditions in the Lungs
Discover how diet affects lung cancer risk. Learn about the link between a high-fat, high-sugar diet and lung cancer ...
New study results reinforce TAGRISSO® (osimertinib) as the backbone therapy for EGFR-mutated lung cancer across stages and settings
New study results presented at the European Lung Cancer Congress (ELCC) 2025, March 26 to 29, demonstrate the role of AstraZeneca’s TAGRISSO® (osimertinib), as monotherapy and as the backbone for ...
CURE13h
Olvi-Vec Shows Responses and Tolerable Safety in Small Cell Lung Cancer
Positive preliminary data from the phase 1b/2 trial evaluating Olvi-Vec in small cell lung cancer have been announced.
Memorial Sloan Kettering Cancer Center2d
New Targeted Therapy Strategies for Addressing Non-Small Cell Lung Cancer Metastatic Disease
Targeted therapies have significantly improved outcomes for patients with non-small cell lung cancer (NSCLC) with actionable mutations. However, many tumors inevitably develop drug resistance and ...
Immutep Doses First Patient in Lung Cancer Trial
Immutep (ASX:IMM) has dosed the first patient in its pivotal Phase III trial evaluating eftilagimod alfa (efti) for the ...
Rheumatology Advisor17h
TNF Inhibitor Use in RA With Early-Stage Cancer Does Not Decrease Survival
In patients with RA, TNF inhibitor use during the 3 years after being diagnosed with early-stage lung, colorectal, or prostate cancer was not linked to decreased survival.